Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine

被引：0
|
作者：
Barabino, L. [1 ]
Galitzia, A. [1 ]
Murru, R. [2 ]
Caocci, G. [1 ,2 ]
Greco, M. [2 ]
Targhetta, C. [2 ]
Angioni, G. [3 ]
Vacca, A. [2 ]
Piras, E. [2 ]
Frau, V. [2 ]
Mulas, O. [1 ,2 ]
LA Nasa, G. [1 ,2 ]
机构：
[1] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy
[2] Osped Oncol A Businco, Hematol & Transplant Ctr, Cagliari, Italy
[3] Brotzu Hosp, Lab Clin Chem Anal & Microbiol, Cagliari, Italy
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2023年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：6914 / 6916
页数：3
相关论文
共 50 条
  • [31] Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
    Favresse, Julien
    Bayart, Jean-Louis
    Mullier, Francois
    Dogne, Jean-Michel
    Closset, Melanie
    Douxfils, Jonathan
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1351.e5 - 1351.e7
  • [32] Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
    Appelman, Brent
    van der Straten, Karlijn
    Lavell, A. H. Ayesha
    Schinkel, Michiel
    Slim, Marleen A.
    Poniman, Meliawati
    Burger, Judith A.
    Oomen, Melissa
    Tejjani, Khadija
    Vlaar, Alexander P. J.
    Wiersinga, W. Joost
    Smulders, Yvo M.
    van Vught, Lonneke A.
    Sanders, Rogier W.
    van Gils, Marit J.
    Bomers, Marije K.
    Sikkens, Jonne J.
    EBIOMEDICINE, 2021, 72
  • [33] A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals
    Blazhevska, Teodora Brnjarchevska
    Sibinovska, Olgica
    Trajkov, Dejan
    Kirijas, Meri
    Arsov, Todor
    Milanovski, Gorjan
    Mladenovska, Olivija Efinska
    Dobrevski, Boban
    Stanchev, Dragica Bliznakovska
    Savevska, Tamara
    Iljoska, Stefani
    Petlichkovski, Aleksandar
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 306 - 306
  • [34] A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals
    Blazhevska, Teodora Brnjarchevska
    Babacic, Haris
    Sibinovska, Olgica
    Dobrevski, Boban
    Kirijas, Meri
    Milanovski, Gorjan
    Arsov, Todor
    Petlichkovski, Aleksandar
    ALLERGY, 2022, 77 (01) : 296 - 298
  • [35] COMPARISON OF SARS-COV-2 VACCINE RESPONSE IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE; MRNA-1273 VACCINE INDUCES HIGHER HUMORAL IMMUNOGENICITY THAN BNT162B2
    Kondo, Y.
    Takeshita, M.
    Uwamino, Y.
    Namkoong, H.
    Saito, S.
    Kikuchi, J.
    Hanaoka, H.
    Suzuki, K.
    Hasegawa, N.
    Murata, M.
    Kaneko, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 370 - 370
  • [36] Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
    Grupper, Ayelet
    Rabinowich, Liane
    Schwartz, Doron
    Schwartz, Idit F.
    Ben-Yehoyada, Merav
    Shashar, Moshe
    Katchman, Eugene
    Halperin, Tami
    Turner, Dan
    Goykhman, Yaacov
    Shibolet, Oren
    Levy, Sharon
    Houri, Inbal
    Baruch, Roni
    Katchman, Helena
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (08) : 2719 - 2726
  • [37] Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients
    Anastasi, Emanuela
    Marziali, Marco
    Preziosi, Adele
    Berardelli, Elena
    Losardo, Anna Annunziata
    Ribersani, Michela
    Pugliese, Pellegrina
    Farina, Antonella
    Mancini, Patrizia
    Angeloni, Antonio
    MICROBES AND INFECTION, 2022, 24 (6-7)
  • [38] Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2
    Firket, Louis
    Descy, Julie
    Seidel, Laurence
    Bonvoisin, Catherine
    Bouquegneau, Antoine
    Grosch, Stephanie
    Jouret, Francois
    Weekers, Laurent
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (11) : 3806 - 3807
  • [39] Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
    Vollenberg, Richard
    Tepasse, Phil-Robin
    Kuehn, Joachim Ewald
    Hennies, Marc
    Strauss, Markus
    Rennebaum, Florian
    Schomacher, Tina
    Boeckel, Goeran
    Lorentzen, Eva
    Bokemeyer, Arne
    Nowacki, Tobias Max
    BIOMEDICINES, 2022, 10 (01)
  • [40] SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
    Falsey, Ann R.
    Frenck, Robert W., Jr.
    Walsh, Edward E.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Bailey, Ruth
    Swanson, Kena A.
    Xu, Xia
    Koury, Kenneth
    Kalina, Warren
    Cooper, David
    Zou, Jing
    Xie, Xuping
    Xia, Hongjie
    Tuereci, Ozlem
    Lagkadinou, Eleni
    Tompkins, Kristin R.
    Shi, Pei-Yong
    Jansen, Kathrin U.
    Sahin, Ugur
    Dormitzer, Philip R.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1627 - 1629
12345